A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma

By van Meerbeeck J.P.   Baas P.   Debruyne C.   Smit E.F.   van Klaveren R.J.   Galdermans D.   Lentz M.A.   Manegold C.   Giaccone G.   for the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 779-783

Elsevier

Access to resources Recommend Favorite

The activity of raltitrexed (Tomudex(R)) in malignant pleural mesothelioma - an EORTC phase II study (08992)

By Baas P.   Ardizzoni A.   Grossi F.   Nackaerts K.   Numico G.   Van Marck E.   van de Vijver M.   Monetti F.   Smid-Geirnaerdt M.J.A.   van Zandwijk N.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 353-357

Elsevier

Access to resources Recommend Favorite

EORTC Group phase II study of oral etoposide for pretreated soft

By Keizer H. Jan   Crowther Derek   Nielsen Ole Steen   Oosterom Allan T. Van   Muguiro Javier Hornedo   Pottelberghe Christine Van   Somers Renier   Tursz Thomas  

Sarcoma, Vol. 1, Iss. 2, 1997-06 ,pp. : 99-102

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C.   Vermorken J.B.   Mickiewicz E.   Chevalier B.   Alvarez A.   Mendiola C.   Pawinski A.   Lentz M.A.   Pecorelli S.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite

Phase II Study of Weekly 4'-Epidoxorubicin in Patients with Metastatic Adenocarcinoma of the Cervix: an EORTC Gynaecological Cancer Cooperative Group Study

By van der Burg M.E.L.   Bolis G.   Bakker P.J.M.   Curran D.   Sahmoud T.   Vermorken J.B.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1513-1515

Elsevier

Access to resources Recommend Favorite